CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![AI medical cloud technology, analyzing patient health data, artificial intelligence agents, smart medical records, digital healthcare solutions-GettyImages-2229247291]( "AI Tools In Informed Consent: What Sponsors Need To Know About Risk")
AI Tools In Informed Consent: What Sponsors Need To Know About RiskAI tools carry different risks. See how they can impact participant communications, where bias and inaccuracies emerge, and why human review is critical to protecting study integrity.
-
![GettyImages-1903424167-medical-meeting-clinical-setting-doctors]( "From Data Delays To Decision Speed")
From Data Delays To Decision SpeedThe biggest risk in modern trials isn’t missing data. It’s delayed insight. Discover how real-time intelligence helps teams act faster, reduce risk, and improve trial execution.
-
![The US Biosimilar Approval Pathway: Policy Precedes Science - A Regulatory Perspective]( "Why Legacy RTSM Systems Create Risk in Biosimilar Trials")
Why Legacy RTSM Systems Create Risk in Biosimilar TrialsLearn how real-time visibility, adaptive supply planning, and proactive risk management can reduce waste and improve study execution.
-
![FDA Approved, Quality medicine, assurance, organization-GettyImages-1653283480]( "The FDA Just Rewrote The Rules For Clinical Trials. Here's What It Means For RTSM.")
The FDA Just Rewrote The Rules For Clinical Trials. Here's What It Means For RTSM.Learn how evolving trial designs are changing RTSM requirements and driving demand for greater flexibility, traceability, and execution quality.
-
![clinical-trial-tech-ai-GettyImages-2226144959]( "The Agentic AI Readiness Myths Costing Sponsors Time")
The Agentic AI Readiness Myths Costing Sponsors TimeMany clinical organizations believe they must clean data and unify systems before adopting agentic AI. New approaches show teams can start now, create value faster, and improve readiness as they scale.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Driving ROI: A Real-Time Clinical Trial Oversight Solution8/3/2026
Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Mid-Study Randomization: Ensuring Data Integrity In Oncology Trials7/5/2026
Miscommunication between supply chain vendors risks costly delays. Discover how unifying physical and digital operations catches issues before they disrupt a trial.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
Developing a therapy for a rare or ultra-rare disease is life-changing work with unique challenges. Examine how natural history data is being used to inform the clinical development process.
It’s about time.
Modern ePRO/eCOA.
Solved.
Don’t wait a lifetime to launch a study that’s just “good enough”. Build and design a data collection experience that patients and sites will love to use.
Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.
Bioforum’s clinical research experts have developed an intuitive and easy-to-navigate analytics and visualization platform.
BioGRID brings clinical trial data together in a clear, focused manner to drive smart decision-making processes.
Biostatistical services, including SAP development, statistical programming in SAS, analysis, submission-ready services and statistical reports are customized and designed specifically to meet your project requirements.
CENTRAL LABORATORIES SOLUTIONS
- Comprehensive Advanced Therapy Analytics
- Drive Automation And Efficiency In Your Interim Lock Process
- Synthetic Control Arm®: The Smart External Control Arm Solution
- Real World Data Solutions
- End-To-End Safety Solutions Designed For Success
- Glioblastoma Multiforme
- Unlock Your Clinical Imaging Data Potential
- Data-Powered Financial Management For Your Clinical Trials
- The Definitive Infrastructure For Modern Drug Development
- Real-World Data And Real-World Evidence
VIDEOS
- Accelerated Recruitment Through AI-Powered Patient Matching At Network Scale
- Endpoint Named A Leader In Everest Group's 2025 Life Sciences RTSM Products PEAK Matrix Assessment
- Human Abuse Potential: Subjective Ratings
- Human Abuse Potential: Participant Recruitment
- Why Now? The Case For Disruptive Technology In Clinical Trials
NEWS
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Univo IRB And The Patient View Announce Partnership
- Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America
- Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience